What medicine is used for aplastic anemia?

Written by Li Fang Fang
Hematology
Updated on September 10, 2024
00:00
00:00

The main drugs used for aplastic anemia are immunosuppressants and cyclosporine. In addition to cyclosporine, low doses of hormones, androgens, and traditional Chinese medicine can also be used to stimulate bone marrow hematopoiesis. If the medication is effective, continue with oral administration; if ineffective, further consideration of bone marrow transplantation is needed. During the treatment process, it is necessary to regularly review the routine blood tests and, if necessary, provide support treatment with red blood cell and platelet transfusions.

Other Voices

doctor image
home-news-image
Written by Li Fang Fang
Hematology
46sec home-news-image

Is aplastic anemia leukemia?

Aplastic anemia is not leukemia, but there is a very small chance that aplastic anemia can transform into leukemia. Aplastic anemia is a bone marrow failure syndrome, and its clinical presentation often includes pancytopenia. It can be classified into acute aplastic anemia and chronic aplastic anemia. Leukemia often manifests with high white blood cell counts, anemia, and low platelet counts. It is caused by the infiltration of leukemia cells into the bone marrow, leading to the suppression of normal hematopoiesis, and is classified as a malignant hematological tumor. Leukemia can be divided into acute leukemia and chronic leukemia.

doctor image
home-news-image
Written by Peng Miao Yun
Internal Medicine
47sec home-news-image

The main diagnostic basis for aplastic anemia

Aplastic anemia is caused by a variety of reasons leading to bone marrow hematopoietic failure. So, what is the main diagnostic basis for diagnosing aplastic anemia? It is primarily the bone marrow examination, which shows decreased or severely decreased proliferation at least in one site, such as active proliferation, significant reduction in megakaryocytes, and an increase in non-hematopoietic cells in the bone marrow's granular components. Additionally, there can be a decrease in total blood cells, white cells, red cells, etc., and a reduction in the absolute value of reticulocytes.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
51sec home-news-image

Can aplastic anemia have children?

Acute aplastic anemia, after effective immunotherapy and discontinuation of medication for more than two years, or after hematopoietic stem cell transplantation and discontinuation of medication for more than two years, it is possible to have children. In cases of chronic aplastic anemia, due to long-term oral intake of immunosuppressants and hematopoietic stimulants, having children is not advised. However, if immunosuppressants and hematopoietic drugs are effective and discontinued for more than two years, and blood levels are acceptable, then it is possible to have children.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
59sec home-news-image

Is aplastic anemia contagious?

Aplastic anemia is not contagious and has a minor hereditary factor, meaning that if a family member has aplastic anemia, it is generally not inherited by the next generation. The cause of aplastic anemia is still unclear, but possible reasons include: 1. Damage to hematopoietic stem cells. After the hematopoietic stem cells are damaged, it leads to limited stem cell proliferation and reduced hematopoiesis. 2. Damage to the hematopoietic microenvironment. Damage to the hematopoietic microenvironment can lead to changes that disrupt the regeneration of hematopoietic stem cells. 3. Immune factors. Immune factors can cause immune damage, directly damaging hematopoietic stem cells, thereby causing bone marrow regeneration disorders.

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
42sec home-news-image

Is it good to transfuse platelets for aplastic anemia with low platelets?

Aplastic anemia is a type of bone marrow failure syndrome, with patients often experiencing a decrease in all blood cells in the peripheral blood. As a result, patients typically face a higher risk of infections and bleeding. Treatment for aplastic anemia is a long-term process, and hematopoiesis often cannot be restored quickly. Therefore, especially in severe cases of aplastic anemia, patients' blood cells remain at relatively low levels for an extended period, placing them at severe risk of infections and bleeding. If platelets fall below 20*10^9/L, it is necessary to administer platelet transfusions to prevent severe bleeding.